D-Cure 25,000 IU Vitamin D Capsules 12 Pieces
€15,00
Sale price
€15,00
Regular price
Skip to product information
D-Cure 25,000 IU Vitamin D Capsules 12 Pieces
€15,00
Sale price
€15,00
Regular price
Used for the initial treatment of symptomatic vitamin D deficiency in adults.
Properties:
D-Cure 25,000 IU hard capsules is a vitamin product: D-Cure 25,000 IU hard capsules contain cholecalciferol (equivalent to vitamin D3).
Indications:
Used for the initial treatment of symptomatic vitamin D deficiency in adults.
Contraindications:
Do not use D-Cure 25,000 IU hard capsules:
- If you are allergic (hypersensitive) to cholecalciferol or to any of the other ingredients of this medicine
- If you have hypercalcemia (increased calcium concentration in the blood)
- If you have hypercalciuria (increased calcium concentration in the urine)
- If you have pseudohypoparathyroidism (disrupted hormone metabolism of the parathyroid gland), because the vitamin D requirement may be reduced as a result of phases of normal vitamin D sensitivity. In this case, there is a risk of prolonged overdose. Better controllable active substances with vitamin D activity are available for this purpose.
- If you have a predisposition to kidney stones
- If you have severe renal insufficiency
- If you have vitamin D hypervitaminosis
- D-Cure 25,000 IU hard capsules are not recommended for children and adolescents under the age of 18.
- This high-strength formulation is not recommended for use by pregnant women and breastfeeding women.
Composition:
Cholecalciferol (vitamin D3); tocopherol acetate, refined olive oil, gelatin
Active composition:
The active substance is cholecalciferol (vitamin D3).
1 hard capsule contains 0.625 mg cholecalciferol, equivalent to 25,000 IU vitamin D3. Directions
for use:
Always use D-Cure 25,000 IU hard capsules exactly as your doctor has told you.
Swallow the capsule with water.
Precautions:
Contact your doctor or pharmacist before using D-Cure 25,000 IU hard capsules:
- If you have impaired renal excretion of calcium and phosphate
- If you are currently being treated with benzothiadiazine derivatives (used to stimulate urinary excretion)
- In immobilized patients, as they are at risk of developing hypercalcemia (increased calcium concentration in the blood) and hypercalciuria (increased calcium concentration in the urine)
- If you have sarcoidosis, because there is a risk of increased conversion of vitamin D into its active form. In this case, the calcium level in your blood and urine must be monitored.
In patients with impaired renal function treated with D-Cure 25,000 IU hard capsules, the effect on the calcium and phosphate balance must be monitored.
If you are using medicines containing vitamin D or analogues, or eating foods or drinking milk fortified with vitamin D, or if there is a high probability that you will be exposed to significant sunlight while using D-Cure 25,000 IU hard capsules, the dose of vitamin D in D-Cure 25,000 IU hard capsules must be taken into account. Additional supplementation with vitamin D or calcium should only take place under medical supervision. In such cases, blood and urine calcium levels must be monitored.
It has been reported that oral administration of a high dose of vitamin D (500,000 IU by means of a single annual bolus) in elderly patients leads to an increased risk of fractures, with the greatest increase observed during the first 3 months after administration.
During long-term treatment with cholecalciferol, blood and urine calcium levels must be monitored and renal function must be checked by measuring serum creatinine. These checks are particularly important in elderly patients and in the event of concomitant treatment with cardiac glycosides (used to stimulate heart muscle function) or diuretics (used to stimulate urine excretion). In the event of hypercalcemia (elevated calcium level in the blood) or signs of impaired renal function, the dose must be reduced or treatment discontinued. It is recommended to reduce the dose or discontinue treatment if the urinary calcium level exceeds 7.5 mmol/24 hours (300 mg/24 hours).
Tell your doctor or pharmacist if you are using, have recently used, or may use any other medicines:
- Rifampicin (antibiotic), isoniazid (antibiotic), phenytoin (used to treat epilepsy), or barbiturates (used to treat epilepsy and sleep disorders and for anesthesia) may reduce the effectiveness of vitamin D.
- Thiazide diuretics (e.g., benzothiadiazine derivatives) are medicines that stimulate urine excretion and can lead to hypercalcemia (increased calcium concentration in the blood) due to reduced calcium excretion through the kidneys. Therefore, calcium levels in the blood and urine must be monitored during long-term treatment.
- Concomitant administration of glucocorticoids (used to treat certain allergic conditions) may reduce the effect of vitamin D.
- The risk of a side effect may increase with the use of cardiac glycosides (used to stimulate heart muscle function) due to increased calcium levels in the blood during treatment with vitamin D (risk of heart rhythm disorders). Your ECG and the calcium levels in your blood and urine must be checked.
- Combination of D-Cure 25,000 IU hard capsules with metabolites or analogues of vitamin D should be avoided.
- Concomitant treatment with ion-exchange resins such as cholestyramine or laxatives such as paraffin oil may reduce gastrointestinal absorption of vitamin D.
- Actinomycin and imidazole antifungals (medicines such as clotrimazole and ketocone, used for the treatment of fungal diseases) may interfere with the metabolism of vitamin D.
Please note that this also applies to medicines you have recently used.
If you are pregnant, think you may be pregnant, are planning to become pregnant, or are breastfeeding, contact your doctor or pharmacist before using this medicine.
Like all medicines, this medicine can cause side effects, although not everyone experiences them.
Keep out of sight and reach of children.
Contents:
12 hard capsules
D-Cure 25,000 IU hard capsules is a vitamin product: D-Cure 25,000 IU hard capsules contain cholecalciferol (equivalent to vitamin D3).
Indications:
Used for the initial treatment of symptomatic vitamin D deficiency in adults.
Contraindications:
Do not use D-Cure 25,000 IU hard capsules:
- If you are allergic (hypersensitive) to cholecalciferol or to any of the other ingredients of this medicine
- If you have hypercalcemia (increased calcium concentration in the blood)
- If you have hypercalciuria (increased calcium concentration in the urine)
- If you have pseudohypoparathyroidism (disrupted hormone metabolism of the parathyroid gland), because the vitamin D requirement may be reduced as a result of phases of normal vitamin D sensitivity. In this case, there is a risk of prolonged overdose. Better controllable active substances with vitamin D activity are available for this purpose.
- If you have a predisposition to kidney stones
- If you have severe renal insufficiency
- If you have vitamin D hypervitaminosis
- D-Cure 25,000 IU hard capsules are not recommended for children and adolescents under the age of 18.
- This high-strength formulation is not recommended for use by pregnant women and breastfeeding women.
Composition:
Cholecalciferol (vitamin D3); tocopherol acetate, refined olive oil, gelatin
Active composition:
The active substance is cholecalciferol (vitamin D3).
1 hard capsule contains 0.625 mg cholecalciferol, equivalent to 25,000 IU vitamin D3. Directions
for use:
Always use D-Cure 25,000 IU hard capsules exactly as your doctor has told you.
Swallow the capsule with water.
Precautions:
Contact your doctor or pharmacist before using D-Cure 25,000 IU hard capsules:
- If you have impaired renal excretion of calcium and phosphate
- If you are currently being treated with benzothiadiazine derivatives (used to stimulate urinary excretion)
- In immobilized patients, as they are at risk of developing hypercalcemia (increased calcium concentration in the blood) and hypercalciuria (increased calcium concentration in the urine)
- If you have sarcoidosis, because there is a risk of increased conversion of vitamin D into its active form. In this case, the calcium level in your blood and urine must be monitored.
In patients with impaired renal function treated with D-Cure 25,000 IU hard capsules, the effect on the calcium and phosphate balance must be monitored.
If you are using medicines containing vitamin D or analogues, or eating foods or drinking milk fortified with vitamin D, or if there is a high probability that you will be exposed to significant sunlight while using D-Cure 25,000 IU hard capsules, the dose of vitamin D in D-Cure 25,000 IU hard capsules must be taken into account. Additional supplementation with vitamin D or calcium should only take place under medical supervision. In such cases, blood and urine calcium levels must be monitored.
It has been reported that oral administration of a high dose of vitamin D (500,000 IU by means of a single annual bolus) in elderly patients leads to an increased risk of fractures, with the greatest increase observed during the first 3 months after administration.
During long-term treatment with cholecalciferol, blood and urine calcium levels must be monitored and renal function must be checked by measuring serum creatinine. These checks are particularly important in elderly patients and in the event of concomitant treatment with cardiac glycosides (used to stimulate heart muscle function) or diuretics (used to stimulate urine excretion). In the event of hypercalcemia (elevated calcium level in the blood) or signs of impaired renal function, the dose must be reduced or treatment discontinued. It is recommended to reduce the dose or discontinue treatment if the urinary calcium level exceeds 7.5 mmol/24 hours (300 mg/24 hours).
Tell your doctor or pharmacist if you are using, have recently used, or may use any other medicines:
- Rifampicin (antibiotic), isoniazid (antibiotic), phenytoin (used to treat epilepsy), or barbiturates (used to treat epilepsy and sleep disorders and for anesthesia) may reduce the effectiveness of vitamin D.
- Thiazide diuretics (e.g., benzothiadiazine derivatives) are medicines that stimulate urine excretion and can lead to hypercalcemia (increased calcium concentration in the blood) due to reduced calcium excretion through the kidneys. Therefore, calcium levels in the blood and urine must be monitored during long-term treatment.
- Concomitant administration of glucocorticoids (used to treat certain allergic conditions) may reduce the effect of vitamin D.
- The risk of a side effect may increase with the use of cardiac glycosides (used to stimulate heart muscle function) due to increased calcium levels in the blood during treatment with vitamin D (risk of heart rhythm disorders). Your ECG and the calcium levels in your blood and urine must be checked.
- Combination of D-Cure 25,000 IU hard capsules with metabolites or analogues of vitamin D should be avoided.
- Concomitant treatment with ion-exchange resins such as cholestyramine or laxatives such as paraffin oil may reduce gastrointestinal absorption of vitamin D.
- Actinomycin and imidazole antifungals (medicines such as clotrimazole and ketocone, used for the treatment of fungal diseases) may interfere with the metabolism of vitamin D.
Please note that this also applies to medicines you have recently used.
If you are pregnant, think you may be pregnant, are planning to become pregnant, or are breastfeeding, contact your doctor or pharmacist before using this medicine.
Like all medicines, this medicine can cause side effects, although not everyone experiences them.
Keep out of sight and reach of children.
Contents:
12 hard capsules